Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mesa Laboratories (MLAB) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Mesa Laboratories (MLAB) over the last 16 years, with Q4 2025 value amounting to 12.25%.

  • Mesa Laboratories' EBITDA Margin rose 30500.0% to 12.25% in Q4 2025 from the same period last year, while for Dec 2025 it was 6.96%, marking a year-over-year increase of 1148100.0%. This contributed to the annual value of 6.78% for FY2025, which is 1326300.0% up from last year.
  • Latest data reveals that Mesa Laboratories reported EBITDA Margin of 12.25% as of Q4 2025, which was up 30500.0% from 7.78% recorded in Q3 2025.
  • Mesa Laboratories' EBITDA Margin's 5-year high stood at 12.25% during Q4 2025, with a 5-year trough of 460.55% in Q1 2024.
  • Over the past 5 years, Mesa Laboratories' median EBITDA Margin value was 5.61% (recorded in 2024), while the average stood at 18.88%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first plummeted by -4614800bps in 2024, then skyrocketed by 4629200bps in 2025.
  • Quarter analysis of 5 years shows Mesa Laboratories' EBITDA Margin stood at 4.59% in 2021, then skyrocketed by 236bps to 6.27% in 2022, then plummeted by -102bps to 0.13% in 2023, then skyrocketed by 7440bps to 9.2% in 2024, then surged by 33bps to 12.25% in 2025.
  • Its EBITDA Margin stands at 12.25% for Q4 2025, versus 7.78% for Q3 2025 and 5.15% for Q2 2025.